Hisanori Umehara
Overview
Explore the profile of Hisanori Umehara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
5483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dong L, Umehara H, Zhong J
Front Med (Lausanne)
. 2022 Jun;
9:941678.
PMID: 35721091
No abstract available.
12.
Chen Y, Cai S, Dong L, Umehara H
Chin Med J (Engl)
. 2022 Jan;
135(4):381-392.
PMID: 34985023
Immunoglobulin G4-related disease (IgG4-RD) is a newly recognized chronic fibro-inflammatory autoimmune disease, and its recognition has been constantly increasing worldwide over the last few years. A correct and timely recognition,...
13.
Tanaka Y, Takeuchi T, Yamanaka H, Nanki T, Umehara H, Yasuda N, et al.
Mod Rheumatol
. 2021 Jan;
31(4):783-789.
PMID: 33427546
Objectives: To evaluate the safety and efficacy of E6011, a novel humanized anti-fractalkine monoclonal antibody, in patients with active rheumatoid arthritis (RA) with an inadequate response to biological disease-modifying antirheumatic...
14.
Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al.
Mod Rheumatol
. 2020 Dec;
31(3):529-533.
PMID: 33274670
IgG4-related disease (IgG4-RD) is a fascinating clinical entity first reported in this century in Japan, and includes a wide variety of diseases, such as formerly named Mikulicz's disease (MD), autoimmune...
15.
Tanaka Y, Takeuchi T, Yamanaka H, Nanki T, Umehara H, Yasuda N, et al.
Arthritis Rheumatol
. 2020 Oct;
73(4):587-595.
PMID: 33038062
Objective: To evaluate the efficacy and safety of E6011, a humanized IgG2 monoclonal antibody against human fractalkine (FKN), in a phase II, double-blind, placebo-controlled study in rheumatoid arthritis (RA) patients....
16.
Wallace Z, Naden R, Chari S, Choi H, Della-Torre E, Dicaire J, et al.
Ann Rheum Dis
. 2019 Dec;
79(1):77-87.
PMID: 31796497
IgG4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ. Correlation among clinical, serological, radiological and pathological data is required for diagnosis. This work was undertaken to develop and...
17.
Wallace Z, Naden R, Chari S, Choi H, Della-Torre E, Dicaire J, et al.
Arthritis Rheumatol
. 2019 Dec;
72(1):7-19.
PMID: 31793250
Objective: IgG4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ. Correlation among clinical, serologic, radiologic, and pathologic data is required for diagnosis. This work was undertaken to develop...
18.
Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, et al.
Mod Rheumatol
. 2019 May;
30(3):551-557.
PMID: 31116057
IgG4-related disease (IgG4-RD) is characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. The pathogenesis of this disease is not clear. Transcriptome analysis was performed to identify...
19.
Umehara H, Okazaki K, Kawano M, Tanaka Y
Mod Rheumatol
. 2018 Dec;
29(2):214-218.
PMID: 30557067
IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. Although IgG4-RD is attracting strong attention...
20.